This announcement is a separate document:
康恩贝：康恩贝2022年股票期权激励计划行权价格调整事项之法律意见书
Zhejiang Conba Pharmaceutical: Legal opinion on the adjustment of exercise price of stock options incentive plan of Zhejiang Conba Pharmaceutical in 2022.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.